From Aptamer Group May 16 2025 Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, presented new data on its Optimer therapeutic delivery vehicle for liver fibrosis at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in New Orleans, LA (13-17 May 2025). New data show Optimer delivery vehicle could be used in precision medicines across diverse fibrotic diseases. Image Credit: Aptamer Group Developed